Retraction: Bmi1 limits dilated cardiomyopathy and heart failure by inhibiting cardiac senescence (Nature Communications (2015) 6 (6473) DOI: 10.1038/ncomms7473);Bmi1 limits dilated cardiomyopathy and heart failure by inhibiting cardiac senescence

Nature Communications

Volumn 6, Issue , 2015, Pages

  Gonzalez Valdes, I ^a   Hidalgo, I ^a   Bujarrabal, A ^a   Lara Pezzi, E ^a   Padron Barthe, L ^a,b   Garcia Pavia, P ^b   Gomez, P ^a   Redondo, J M ^a   Ruiz Cabello, J M ^c   Jimenez Borreguero, L J ^c   Enriquez, J A ^a   De La Pompa, J L ^a   Hidalgo, A ^a   Gonzalez, S ^a  

^a CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BMI1 PROTEIN; CHEMOKINE; COLLAGEN; CYCLIN A2; CYCLIN D2; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DOXYCYCLINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HISTONE H2A; INTERLEUKIN 6; INTERLEUKIN 7; METALLOPROTEINASE; MYOSIN HEAVY CHAIN ALPHA; SOMATOMEDIN BINDING PROTEIN; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA3; BMI1 PROTEIN, HUMAN; ISOPRENALINE;

CARDIOLOGY; CARDIOVASCULAR DISEASE; GENE EXPRESSION; PATHOLOGY; PHENOTYPE; RODENT;

ADULT; ADULT STEM CELL; AGING; ANIMAL CELL; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; GENE DELETION; GENE OVEREXPRESSION; HEART DEVELOPMENT; HEART FAILURE; HEART HYPERTROPHY; HEART PROTECTION; HEART VENTRICLE CONTRACTILITY; HEART VENTRICLE FAILURE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LUNG CONGESTION; LUNG WEIGHT; MALE; MOUSE; NONHUMAN; PARABIOSIS; PHENOTYPE; PROTEIN FUNCTION; RNA ANALYSIS; SENESCENCE; TISSUE REPAIR; ANIMAL; ANIMAL EMBRYO; C57BL MOUSE; CELL AGING; CHEMICALLY INDUCED; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; HEART CONTRACTION; HEART MUSCLE; HEART MUSCLE CELL; HEART VENTRICLE; METABOLISM; PARACRINE SIGNALING; PATHOLOGY; TRANSGENIC MOUSE;

MUS;

AGING; ANIMALS; CARDIOMYOPATHY, DILATED; CELL AGING; CYCLIN-DEPENDENT KINASE INHIBITOR P16; EMBRYO, MAMMALIAN; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART FAILURE; HEART VENTRICLES; HUMANS; ISOPROTERENOL; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOCARDIAL CONTRACTION; MYOCARDIUM; MYOCYTES, CARDIAC; PARACRINE COMMUNICATION; POLYCOMB REPRESSIVE COMPLEX 1; TRANSCRIPTOME;

EID: 84924359164     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms14006     Document Type: Erratum

References (43)

1. McNally, E. M., Golbus, J. R. & Puckelwartz, M. J. Genetic mutations and mechanisms in dilated cardiomyopathy. J. Clin. Invest. 123, 19-26 (2013).
2. Harvey, P. A. & Leinwand, L. A. The cell biology of disease: cellular mechanisms of cardiomyopathy. J. Cell Biol. 194, 355-365 (2011).
3. Sauvageau, M. & Sauvageau, G. Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer. Cell Stem Cell 7, 299-313 (2010).
4. Dobreva, G. & Braun, T. When silence is broken: polycomb group proteins in heart development. Circ. Res. 110, 372-374 (2012).
5. Chang, C. P. & Bruneau, B. G. Epigenetics and cardiovascular development. Annu. Rev. Physiol. 74, 41-68 (2012).
6. Hang, C. T. et al. Chromatin regulation by Brg1 underlies heart muscle development and disease. Nature 466, 62-67 (2010).
7. Delgado-Olguin, P. et al. Epigenetic repression of cardiac progenitor gene expression by Ezh2 is required for postnatal cardiac homeostasis. Nat. Genet. 44, 343-347 (2012).
8. Ng, S. B. et al. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat. Genet. 42, 790-793 (2010).
9. Ieda, M. et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142, 375-386 (2010).
10. Wamstad, J. A. et al. Dynamic and coordinated epigenetic regulation of developmental transitions in the cardiac lineage. Cell 151, 206-220 (2012).
11. Bracken, A. P. & Helin, K. Polycomb group proteins: navigators of lineage pathways led astray in cancer. Nat. Rev. Cancer 9, 773-784 (2009).
12. Salama, R., Sadaie, M., Hoare, M. & Narita, M. Cellular senescence and its effector programs. Genes Dev. 28, 99-114 (2014).
13. Krizhanovsky, V. et al. Senescence of activated stellate cells limits liver fibrosis. Cell 134, 657-667 (2008).
14. Narita, M. et al. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113, 703-716 (2003).
15. Collado, M., Blasco, M. A. & Serrano, M. Cellular senescence in cancer and aging. Cell 130, 223-233 (2007).
16. Kuilman, T., Michaloglou, C., Mooi, W. J. & Peeper, D. S. The essence of senescence. Genes Dev. 24, 2463-2479 (2010).
17. Acosta, J. C. et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat. Cell Biol. 15, 978-990 (2013).
18. Di Croce, L. & Helin, K. Transcriptional regulation by Polycomb group proteins. Nat. Struct. Mol. Biol. 20, 1147-1155 (2013).
19. Jacobs, J. J., Kieboom, K., Marino, S., DePinho, R. A. & van Lohuizen, M. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397, 164-168 (1999).
20. Bruggeman, S. W. et al. Ink4a and Arf differentially affect cell proliferation and neural stem cell self-renewal in Bmi1-deficient mice. Genes Dev. 19, 1438-1443 (2005).
21. Molofsky, A. V. et al. Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing. Nature 443, 448-452 (2006).
22. Oguro, H. et al. Differential impact of Ink4a and Arf on hematopoietic stem cells and their bone marrow microenvironment in Bmi1-deficient mice. J. Exp. Med. 203, 2247-2253 (2006).
23. Akala, O. O. et al. Long-term haematopoietic reconstitution by Trp53-/-p16Ink4a-/-p19Arf-/-multipotent progenitors. Nature 453, 228-232 (2008).
24. Arranz, L. et al. Bmi1 is critical to prevent Ikaros-mediated lymphoid priming in hematopoietic stem cells. Cell Cycle 11, 65-78 (2012).
25. Moses, K. A., DeMayo, F., Braun, R. M., Reecy, J. L. & Schwartz, R. J. Embryonic expression of an Nkx2-5/Cre gene using ROSA26 reporter mice. Genesis 31, 176-180 (2001).
26. Agah, R. et al. Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. J. Clin. Invest. 100, 169-179 (1997).
27. Sohal, D. S. et al. Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein. Circ. Res. 89, 20-25 (2001).
28. Breckenridge, R. A. et al. Overexpression of the transcription factor Hand1 causes predisposition towards arrhythmia in mice. J. Mol. Cell Cardiol. 47, 133-141 (2009).
29. North, B. J. & Sinclair, D. A. The intersection between aging and cardiovascular disease. Circ. Res. 110, 1097-1108 (2012).
30. Hidalgo, I. et al. Ezh1 is required for hematopoietic stem cell maintenance and prevents senescence-like cell cycle arrest. Cell Stem Cell 11, 649-662 (2012).
31. Lowe, S. W., Cepero, E. & Evan, G. Intrinsic tumour suppression. Nature 432, 307-315 (2004).
32. Coppe, J. P., Desprez, P. Y., Krtolica, A. & Campisi, J. The senescenceassociated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. 5, 99-118 (2010).
33. Agherbi, H. et al. Polycomb mediated epigenetic silencing and replication timing at the INK4a/ARF locus during senescence. PLoS ONE 4, e5622 (2009).
34. Gonzalez, S. et al. Oncogenic activity of Cdc6 through repression of the INK4/ARF locus. Nature 440, 702-706 (2006).
35. Debacq-Chainiaux, F., Erusalimsky, J. D., Campisi, J. & Toussaint, O. Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat. Protoc. 4, 1798-1806 (2009).
36. Shioya, T. A simple technique for isolating healthy heart cells from mouse models. J. Physiol. Sci. 57, 327-335 (2007).
37. Takeda, N. et al. Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload. J. Clin. Invest. 120, 254-265 (2010).
38. Krimpenfort, P. et al. p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a. Nature 448, 943-946 (2007).
39. Loffredo, F. S. et al. Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell 153, 828-839 (2013).
40. Campisi, J. Cellular senescence: putting the paradoxes in perspective. Curr. Opin. Genet. Dev. 21, 107-112 (2011).
41. Addis, R. C. & Epstein, J. A. Induced regeneration-the progress and promise of direct reprogramming for heart repair. Nat. Med. 19, 829-836 (2013).
42. Gonzalez, S., Pisano, D. G. & Serrano, M. Mechanistic principles of chromatin remodeling guided by siRNAs and miRNAs. Cell Cycle 7, 2601-2608 (2008).
43. Schmitt, J. P. et al. Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science 299, 1410-1413 (2003).